Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation

British Journal of Anaesthesia

Volumn 100, Issue 4, 2008, Pages 504-508

  Blasco, V ^a,b   Leone, M ^a,b   Antonini, F ^a,b   Geissler, A ^a,b   Albanese J ^a,b   Martin, C ^a,b  

^a HÔPITAL NORD   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Fluids, i.v.; Head, injury; Kidney, failure; Kidney, transplantation

Indexed keywords

HETASTARCH; NORADRENALIN; CREATININE; DRUG DERIVATIVE; HES 130 0.4; HES 130-0.4; HYDROXYETHYLSTARCH 200; PLASMA SUBSTITUTE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN DEATH; COLD ISCHEMIA; COLLOID; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DELAYED GRAFT FUNCTION; FEMALE; HUMAN; INTENSIVE CARE UNIT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; RESUSCITATION; ADOLESCENT; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; DONOR; KIDNEY; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN DEATH; CASE-CONTROL STUDIES; CREATININE; DELAYED GRAFT FUNCTION; FEMALE; HETASTARCH; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PLASMA SUBSTITUTES; RESUSCITATION; TISSUE DONORS;

EID: 41949136382     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aen001     Document Type: Article

References (26)

1. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996; 348: 1620-2
2. Davidson IJ. Renal impact of fluid management with colloids: a comparative review. Eur J Anaesthesiol 2006; 23: 721-38
3. Zeier M, Döhler B, Opelz G, Ritz E. The effect of donor gender on graft survival. J Am Soc Nephrol 2002; 13: 2570-6
4. Gore JL, Pham PT, Danovitch GM, et al. Obesity and outcome following renal transplantation. Am J Transplant 2006; 6: 357-63
5. Schnuelle P, Berger S, de Boer J, et al. Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation. Transplantation 2001; 72: 455-63
6. Pessione F, Cohen S, Durand D, et al. Multivariate analysis of donor risk factors for graft survival in kidney transplantation. Transplantation 2003; 75: 266-7
7. Gira M, Bertola JP, Foucher Y, et al. Effect of brain-dead donor resuscitation on delayed graft function: results of a monocentric analysis. Transplantation 2007; 83: 1174-81
8. Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet 2004; 364: 1814
9. Joosten SA, Sijpkens YW, van Kooten C, Paul LC. Chronic renal allograft rejection: pathophysiologic considerations. Kidney Int 2005; 68: 1-13
10. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326-33
11. Treib J, Baron JF, Grauer MT, Strauss RG. An international review of hydroxyethyl starches. Intensive Care Med 1999; 25: 258-68
12. Legendre C, Thervet E, Page B, Percheron A, Noel LH, Kreis H. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 1993; 342: 248-9
13. Standl T, Lipfert B, Reeker W, Schulte am EJ, Lorke DE. Acute effects of complete blood exchange with ultra-purified haemoglobin solution or hydroxyethyl starch on liver and kidney in the animal model. Anasthesiol Intensivmed Notfallmed Schmerzther 1996; 31: 354-61
14. DiScala VA, Mautner W, Cohen JA, Levitt MF, Churg J, Yunis SL. Tubular alterations produced by osmotic diuresis with mannitol. Ann Intern Med 1965; 63: 767-75
15. Diomi P, Ericsson JL, Matheson NA. Effects of dextran 40 on urine flow and composition during renal hypoperfusion in dogs with osmotic nephrosis. Ann Surg 1970; 172: 813-24
16. Moreau JF, Noel LH, Droz D. Proximal renal tubular vacuolization induced by iodinated contrast media, or so-called 'osmotic nephrosis'. Invest Radiol 1993; 28: 187-90
17. Ahsan N, Palmer BF, Wheeler D, Greenlee RG, Jr, Toto RD. Intravenous immunoglobulin-induced osmotic nephrosis. Arch Intern Med 1994; 154: 1985-7
18. Deman A, Peeters P, Sennesael J. Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: a retrospective, multicentre analysis. Nephrol Dial Transplant 1999; 14: 1517-20
19. Ickx BE, Bepperling F, Melot C, Schulman C, Van der Linden PJ. Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution. Br J Anaesth 2003; 91: 196-202
20. Gandhi SD, Weiskopf RB, Jungheinrich C, et al. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch. Anesthesiology 2007; 106: 1120-7
21. Langeron O, Doelberg M, Ang ET, Bonnet F, Capdevila X, Coriat P. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 2001; 92: 855-62
22. Sander O, Reinhart K, Meier-Hellmann A. Equivalence of hydroxyethyl starch HES 130/0. 4 and HES 200/0.5 for perioperative volume replacement in major gynaecological surgery. Acta Anaesthesiol Scand 2003; 47: 1151-8
23. Neff TA, Doelberg M, Jungheinrich C, Sauerland A, Spahn DR, Stocker R. Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe HES injury. Anesth Analg 2003; 96: 1453-9
24. Winkelmayer WC, Glynn RJ, Levin R, Avorn J. Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int 2003; 64: 1046-9
25. Kwon OJ, Lee HG, Kwak JY. The impact of donor and recipient age on the outcome of kidney transplantation. Transplant Proc 2004; 36: 2043-5
26. Kunzendorf U, Hohenstein B, Oberbarnscheid M, et al. Duration of donor brain death and its influence on kidney graft function. Am J Transplant 2002; 2: 292-4